Early data from Moderna Inc's COVID-19 vaccine, the first to be tested in the United States, showed that it produced protective antibodies in a small group of healthy volunteers, the company said on Monday. The data are from eight people who took part in a safety trial that kicked off in March as the global pandemic caused by the novel coronavirus was spreading. In the trial of 45 volunteers, conducted by the...
Full ArticleUS COVID-19 vaccine green lighted for second stage of human testing
WorldNews
0 shares
1 views
You might like
Related news coverage
Nvidia & darpa biohybrid
Rumble
https://www.youtube.com/watch?v=0Hg7XhbXuac . No One is Talking About What Just Happened..
-
Coronavirus: What’s happening in the labs of pharma companies worldwide
Proactive Investors
-
Global Economy Recovery After Crisis Largely Depends On State Policies – Analysis
Eurasia Review
-
S&P/ASX 200 lifts strongly for a third day; market near 10-week high
Proactive Investors
-
Doordash and Pizza Arbitrage
Proactive Investors
Advertisement
More coverage
Saudi Arabia: Coronavirus Adds Momentum To Search For MERS Treatment
Eurasia Review
By Jumana Khamis
The race is on like never before in human history. As the number of confirmed coronavirus disease..
-
Close Encounters Of The COVID Kind – OpEd
Eurasia Review
-
Coronavirus: what’s happening in the labs of pharma companies worldwide
Proactive Investors
-
NA Proactive news snapshot: Milestone Scientific, Orgenesis, TRACON Pharmaceuticals, Codebase Ventures, Arcadia Biosciences UPDATE ...
Proactive Investors
-
The Worst Is Yet To Come: Contact Tracing, Immunity Cards And Mass Testing – OpEd
Eurasia Review